We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002938:SZSEAvary Holding (Shenzhen) Co., Ltd. Class A Analysis

Data as of 2026-03-15 - not real-time

CN¥51.13

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Avary Holding is trading at CNY 51.13, which sits below its 20‑day (≈55.7) and 50‑day (≈55.4) simple moving averages, indicating short‑term weakness despite a longer‑term bullish bias from the 200‑day SMA (≈48.2). The RSI of ~41 suggests the stock is not yet oversold, while a bearish MACD histogram reinforces a near‑term downside pressure. Fundamentally, the company trades at a forward PE of ~21× versus an industry average of ~34×, and its trailing PE of ~29× is modestly below peers, hinting at relative valuation comfort. However, the DCF‑derived fair value of under CNY 5 is dramatically lower than the market price, flagging a potential overvaluation gap. The dividend yield of ~2% with a payout ratio near 57% appears sustainable given strong operating cash flow and modest free cash flow generation. Volatility is high at ~60% over 30 days, but beta is only ~0.65, suggesting market‑wide swings are somewhat muted for this stock. Overall, the blend of a solid dividend, decent ROE (~12.8%), and modest growth (≈1.2% revenue CAGR) supports a value‑oriented stance, while technical signals caution against immediate upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume
  • Price below short‑term SMAs
  • Proximity to support at ~48.4

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive forward PE relative to industry
  • Target price upside of ~20% from analyst consensus
  • Sustainable dividend yield

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable cash generation and ROE
  • Long‑term demand for electronic components
  • Reasonable leverage with ample cash reserves

Key Metrics & Analysis

Financial Health

Revenue Growth1.20%
Profit Margin10.53%
P/E Ratio29.4
ROE12.75%
ROA5.00%
Debt/Equity15.71
P/B Ratio3.6
Op. Cash FlowCN¥8.4B
Free Cash FlowCN¥344.8M
Industry P/E33.7

Technical Analysis

TrendBullish
RSI41.5
SupportCN¥48.38
ResistanceCN¥63.30
MA 20CN¥55.67
MA 50CN¥55.37
MA 200CN¥48.18
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueCN¥4.96
Target PriceCN¥61.34
Upside/Downside19.97%
GradeFair
TypeValue
Dividend Yield1.96%

Risk Assessment

Beta0.65
Volatility60.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.